Cite
HARVARD Citation
Aggarwal, R. et al. (2020). Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level. Scandinavian journal of rheumatology. pp. 405-411. [Online].